Ocugen (OCGN) Net Cash Flow Growth (1y) (2015 - 2026)
Ocugen (OCGN) Net Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | 163.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 163.68% |
| Dec 31, 2025 | -170.69% |
| Sep 30, 2025 | -76.06% |
| Jun 30, 2025 | -3.64% |
| Mar 31, 2025 | -58.14% |
| Dec 31, 2024 | 241.31% |
| Sep 30, 2024 | 234.50% |
| Jun 30, 2024 | -547.18% |
| Mar 31, 2024 | -40.73% |
| Dec 31, 2023 | 41.72% |
| Sep 30, 2023 | -27.44% |
| Jun 30, 2023 | 115.55% |
| Mar 31, 2023 | -126.72% |
| Dec 31, 2022 | -93.96% |
| Sep 30, 2022 | -61.86% |
| Jun 30, 2022 | -121.07% |
| Mar 31, 2022 | 67.75% |
| Dec 31, 2021 | -351.19% |
| Sep 30, 2021 | -300.41% |
| Jun 30, 2021 | 501.70% |